Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | SUMO1/sentrin specific peptidase 6 | Starlite/ChEMBL | No references |
Homo sapiens | SUMO1/sentrin specific peptidase 7 | Starlite/ChEMBL | No references |
Homo sapiens | SUMO/sentrin specific peptidase family member 8 | Starlite/ChEMBL | No references |
Homo sapiens | caspase 3, apoptosis-related cysteine peptidase | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | sentrin-specific protease 1 | SUMO/sentrin specific peptidase family member 8 | 212 aa | 197 aa | 23.4 % |
Brugia malayi | Cell death protein 3 precursor | caspase 3, apoptosis-related cysteine peptidase | 277 aa | 253 aa | 38.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | caspase-3 (C14 family) | 0.012 | 0.2633 | 0.0868 |
Echinococcus granulosus | sentrin specific protease 8 | 0.0111 | 0.1933 | 0.1933 |
Trichomonas vaginalis | Sentrin-specific protease, putative | 0.0111 | 0.1933 | 0.5 |
Echinococcus granulosus | caspase 3 apoptosis cysteine peptidase | 0.012 | 0.2633 | 0.2633 |
Trichomonas vaginalis | Clan CE, family C48, Ulp1-like cysteine peptidase | 0.0111 | 0.1933 | 0.5 |
Echinococcus granulosus | expressed conserved protein | 0.0163 | 0.616 | 0.616 |
Schistosoma mansoni | caspase-7 (C14 family) | 0.012 | 0.2633 | 0.0868 |
Brugia malayi | Ulp1 protease family, C-terminal catalytic domain containing protein | 0.0111 | 0.1933 | 0.5 |
Echinococcus multilocularis | caspase 3, apoptosis cysteine peptidase | 0.012 | 0.2633 | 0.2633 |
Entamoeba histolytica | Ulp1 protease family, C-terminal catalytic domain containing protein | 0.021 | 1 | 1 |
Echinococcus multilocularis | sentrin specific protease 8 | 0.0111 | 0.1933 | 0.1933 |
Schistosoma mansoni | family C48 unassigned peptidase (C48 family) | 0.021 | 1 | 1 |
Echinococcus multilocularis | sentrin specific protease 7 | 0.021 | 1 | 1 |
Trichomonas vaginalis | Clan CE, family C48, Ulp1-like cysteine peptidase | 0.0111 | 0.1933 | 0.5 |
Echinococcus multilocularis | expressed conserved protein | 0.0163 | 0.616 | 0.616 |
Echinococcus multilocularis | caspase | 0.012 | 0.2633 | 0.2633 |
Echinococcus granulosus | caspase | 0.012 | 0.2633 | 0.2633 |
Trypanosoma cruzi | hypothetical protein | 0.0111 | 0.1933 | 0.5 |
Trichomonas vaginalis | Clan CE, family C48, Ulp1-like cysteine peptidase | 0.0111 | 0.1933 | 0.5 |
Loa Loa (eye worm) | Ulp1 protease | 0.0111 | 0.1933 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 0.83 uM | PUBCHEM_BIOASSAY: SAR Analysis of small molecule inhibitors of Sentrin-specific protease 6 (SENP6) using a Luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2582, AID2599] | ChEMBL. | No reference |
IC50 (functional) | = 0.83 uM | PUBCHEM_BIOASSAY: SAR Analysis of small molecule inhibitors of Sentrin-specific protease 8 (SENP8) using a Luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2540, AID2575] | ChEMBL. | No reference |
IC50 (functional) | = 1.1 uM | PUBCHEM_BIOASSAY: SAR Analysis of small molecule inhibitors of Sentrin-specific protease 7 (SENP7) using a Luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID434973, AID434986] | ChEMBL. | No reference |
IC50 (functional) | = 2.3 uM | PUBCHEM_BIOASSAY: SAR Analysis of small molecule inhibitors of Sentrin-specific proteases (SENPs) using a Caspase-3 Selectivity assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2540, AID2599, AID434973, AID489001] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.